Beam Therapeutics Inc. (BEAM)

NMS – Real Time Price. Currency in USD

26.84

-0.01 (-0.02%)

Market open: Aug 12, 2026, 1:47 PM EDT

27.00

+0.15 (0.56%)

Previous after-hours: Aug 11, 2026, 7:38 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

140M

64M

378M

61M

Cost of goods sold

-22M

-20M

-23M

Gross Profit

117M

42M

358M

38M

Operating expenses (excl. COGS)

-501M

-457M

-534M

-377M

Operating Income

-384M

-416M

-176M

-338M

Non-operating income, total

304M

39M

45M

78M

Pretax income

-80M

-377M

-131M

-260M

Equity in earnings

-26M

Taxes

-39K

-1M

-3M

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-80M

-377M

-133M

-289M

Discontinued operations

Net income

-80M

-377M

-133M

-289M

Dilution adjustment

Preferred dividends

Beam Therapeutics Inc. (BEAM)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Beam Therapeutics Inc. (BEAM)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Beam Therapeutics Inc. (BEAM)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Beam Therapeutics Inc. (BEAM)

Income Statement (Annual)

Income Statement (Annual)